JOYLENE FADRIGO: Open Payments
NPI 1265997571 · HUMBLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 37 payments from 16 companies in 2025. Trend: 2023 $838 · 2024 $1,216 · 2025 $1,006
Food & beverage: $1,006
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 5 | $179 |
| Novo Nordisk Inc | 8 | $163 |
| AstraZeneca Pharmaceuticals LP | 3 | $150 |
| Merck Sharp & Dohme LLC | 6 | $120 |
| Amgen Inc. | 1 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Boston Scientific Corporation | 2 | $52 |
| Kestra Medical Technology Services, Inc. | 1 | $36 |
| Smith+Nephew, Inc. | 1 | $25 |
| Edwards Lifesciences Corporation | 1 | $24 |
Products named: Attruby, WAINUA, Wegovy, VERQUVO, REPATHA, JARDIANCE, WATCHMAN FLX, Ozempic.
Industry payments across TX — which companies pay providers there.
